Compare RYAAY & LH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAAY | LH |
|---|---|---|
| Founded | 1985 | 1971 |
| Country | Ireland | United States |
| Employees | N/A | 70000 |
| Industry | Air Freight/Delivery Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8B | 25.9B |
| IPO Year | 2003 | 2005 |
| Metric | RYAAY | LH |
|---|---|---|
| Price | $56.59 | $339.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | $78.00 | ★ $311.33 |
| AVG Volume (30 Days) | ★ 1.1M | 683.3K |
| Earning Date | 05-18-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.54% | 1.12% |
| EPS Growth | N/A | ★ 18.33 |
| EPS | N/A | ★ 6.99 |
| Revenue | N/A | ★ $13,951,700,000.00 |
| Revenue This Year | $11.99 | $8.26 |
| Revenue Next Year | $6.32 | $4.81 |
| P/E Ratio | ★ $12.60 | $48.12 |
| Revenue Growth | N/A | ★ 7.25 |
| 52 Week Low | $53.14 | $244.52 |
| 52 Week High | $74.24 | $338.19 |
| Indicator | RYAAY | LH |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 76.26 |
| Support Level | $55.78 | $250.64 |
| Resistance Level | $61.54 | N/A |
| Average True Range (ATR) | 1.07 | 6.58 |
| MACD | -0.29 | 0.53 |
| Stochastic Oscillator | 33.18 | 92.91 |
Ryanair is Europe's largest low-cost airline, known for its extensive network and highly efficient business model. Operating over 3,600 flights daily across 240-plus destinations in 40 countries, Ryanair has built its success on offering affordable air travel while maintaining tight control over costs. The airline primarily uses Boeing 737 aircraft, including the newer 737 8-200 "Gamechanger" variant, which simplifies operations and reduces expenses. Ryanair focuses on high passenger volume, ancillary revenue, and operational efficiency, ensuring its position as a leading airline in Europe.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.